Financial disclosures of scientific papers presented at the 2003 RSNA Annual Meeting: association with reporting of non-Food and Drug Administration-approved uses of industry products

Radiology
Stephen D BrownSamuel A McDaniel

Abstract

To retrospectively characterize the extent and nature of financial relationships with industry that are disclosed in the abstracts of scientific papers presented at the 2003 Radiological Society of North America (RSNA) Annual Meeting and to retrospectively assess whether the presence of relationships between researchers and industry was associated with a discussion on the use of products or devices that are not yet approved by the U.S. Food and Drug Administration (FDA). Printed abstracts of scientific papers published in the 2003 Radiological Society of North America Scientific Assembly and Annual Meeting Program were classified according to the number and type of financial relationships disclosed. Also recorded was whether the abstracts discussed non-FDA-approved use of a product. Abstracts with and those without disclosures were then compared by using the Fisher exact test with respect to the percentage of abstracts that reported non-FDA-approved use. Of the 1549 published abstracts, 271 (17%) disclosed at least one author with financial ties to a company whose products or services were reported. The most common disclosures were for authors who were employees (39%), corporate grant recipients (34%), corporate consultants (23...Continue Reading

References

Aug 19, 1993·The New England Journal of Medicine·D F Thompson
Dec 5, 1996·The New England Journal of Medicine·D BlumenthalK S Louis
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M FriedbergC L Bennett
May 18, 2000·The New England Journal of Medicine·T Bodenheimer
Nov 1, 2000·JAMA : the Journal of the American Medical Association·E A Boyd, L A Bero
Sep 15, 2001·The New England Journal of Medicine·F DavidoffM S Wilkes
Mar 5, 2002·Annals of Internal Medicine·Susan L Coyle, UNKNOWN Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine
Mar 5, 2002·Annals of Internal Medicine·Susan L Coyle, UNKNOWN Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine
Jan 22, 2003·JAMA : the Journal of the American Medical Association·Justin E BekelmanCary P Gross
May 15, 2003·JAMA : the Journal of the American Medical Association·Arnold S Relman, UNKNOWN ACCME
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Jan 23, 2004·The New England Journal of Medicine·Robert Steinbrook
Mar 30, 2004·Health Affairs·Elizabeth A BoydLisa A Bero
Oct 8, 2004·The New England Journal of Medicine·Eric J Topol
Oct 19, 2004·Journal of the American College of Cardiology·Alice K JacobsShahbudin H Rahimtoola
Oct 29, 2004·The New England Journal of Medicine·David Blumenthal
Jan 29, 2005·Accountability in Research·Eric G CampbellDavid Blumenthal
Feb 11, 2005·The New England Journal of Medicine·Robert Steinbrook
Jun 24, 2005·The New England Journal of Medicine·Jerry Avorn
Jun 24, 2005·The New England Journal of Medicine·Henry A Waxman
Jul 15, 2005·The New England Journal of Medicine·Eric J Topol

❮ Previous
Next ❯

Citations

Jun 3, 2009·Techniques in Coloproctology·A Amato
Jul 22, 2010·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Herbert Y Kressel, William W Olmsted
Mar 17, 2010·European Journal of Radiology·Ali HassanHatem Alkadhi
Jul 9, 2009·Journal of Vascular and Interventional Radiology : JVIR·Mark Otto BaerlocherJohn F Cardella
Jan 23, 2009·Journal of Vascular and Interventional Radiology : JVIR·Mark Otto BaerlocherJohn F Cardella
Jul 31, 2013·American Heart Journal·Doron SudarskyShahar Lavi
Feb 5, 2008·Journal of the American College of Radiology : JACR·Giles W L BolandWilliam McCormick
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lindsay A HampsonEzekiel J Emanuel
Nov 6, 2009·The New England Journal of Medicine·Caroline AchardMicheline Misrahi
Dec 14, 2007·European Journal of Clinical Pharmacology·Dietmar Trenk, Franz-Josef Neumann
Apr 28, 2010·Expert Review of Neurotherapeutics·Mathias Buttmann
May 21, 2011·Current Atherosclerosis Reports·Robert A TaylorScott E Kasner
Mar 8, 2008·Taehan Kanho Hakhoe chi·Yoonmi HongChang Gi Park
Oct 10, 2019·Journal of Applied Microbiology·A Bashir, P Lambert
Mar 2, 2010·Journal of Korean Medical Science·Ha Na YangYoung Hee Choi
Feb 22, 2011·The British Journal of Dermatology·A SchnuchW Uter
Mar 29, 2011·American Journal of Clinical Oncology·Sekwon JangNavneet S Majhail

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
A Wazana
The New England Journal of Medicine
Jay S YadavStenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators
JAMA : the Journal of the American Medical Association
Niteesh K ChoudhryAllan S Detsky
© 2022 Meta ULC. All rights reserved